Lim JT - Search Results

1

Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Masuda M, et al. Among authors: lim jt. J Exp Ther Oncol. 2002 Nov-Dec;2(6):350-9. doi: 10.1046/j.1359-4117.2002.01062.x. J Exp Ther Oncol. 2002. PMID: 12440226

2

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB. Suzui M, et al. Among authors: lim jt. Cancer Res. 2002 Jul 15;62(14):3997-4006. Cancer Res. 2002. PMID: 12124333

3

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Masuda M, Suzui M, Lim JT, Weinstein IB. Masuda M, et al. Among authors: lim jt. Clin Cancer Res. 2003 Aug 15;9(9):3486-91. Clin Cancer Res. 2003. PMID: 12960141

4

Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells.

Shimizu M, Suzui M, Deguchi A, Lim JT, Weinstein IB. Shimizu M, et al. Among authors: lim jt. Clin Cancer Res. 2004 Feb 1;10(3):1130-40. doi: 10.1158/1078-0432.ccr-0714-3. Clin Cancer Res. 2004. PMID: 14871993

5

Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.

Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Suzui M, et al. Among authors: lim jt. Mol Cancer Ther. 2004 Mar;3(3):309-16. Mol Cancer Ther. 2004. PMID: 15026551

6

(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.

Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. Shimizu M, et al. Among authors: lim jt. Clin Cancer Res. 2005 Apr 1;11(7):2735-46. doi: 10.1158/1078-0432.CCR-04-2014. Clin Cancer Res. 2005. PMID: 15814656

7

Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.

Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB. Lim JT, et al. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84. doi: 10.1158/1078-0432.CCR-05-2051. Clin Cancer Res. 2006. PMID: 16740773

8

Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.

Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB. Lim JT, et al. Clin Cancer Res. 2003 Oct 15;9(13):4972-82. Clin Cancer Res. 2003. PMID: 14581372

9

Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells.

Einbond LS, Shimizu M, Xiao D, Nuntanakorn P, Lim JT, Suzui M, Seter C, Pertel T, Kennelly EJ, Kronenberg F, Weinstein IB. Einbond LS, et al. Among authors: lim jt. Breast Cancer Res Treat. 2004 Feb;83(3):221-31. doi: 10.1023/B:BREA.0000014043.56230.a3. Breast Cancer Res Treat. 2004. PMID: 14758092

10

Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.

Shimizu M, Suzui M, Deguchi A, Lim JT, Xiao D, Hayes JH, Papadopoulos KP, Weinstein IB. Shimizu M, et al. Among authors: lim jt. Clin Cancer Res. 2004 Oct 1;10(19):6710-21. doi: 10.1158/1078-0432.CCR-04-0659. Clin Cancer Res. 2004. PMID: 15475462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters